MVision AI

Koti
Suomi
Helsinki
MVision AI

Yhteystiedot, kartta ja reittiohjeet, yhteydenottolomake, aukioloajat, palvelut, arvostelut, kuvat, videot ja ilmoitukset MVision AI, Terveys, PaciuksenKatu 29, Helsinki :ltä.

MVision develops AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.

31/03/2026

Adaptive radiotherapy is becoming an important step forward in how radiation treatment responds to anatomical change.

During a multi-week treatment course, tumors and surrounding organs rarely stay in the same position or shape. New adaptive workflows allow clinicians to respond to these changes rather than rely only on a pre-treatment plan.

Advances in imaging, computing, and AI are making this approach increasingly practical in clinical settings.

We recently explored how adaptive radiotherapy is being used today, where it shows the most promise, and what current clinical evidence tells us.

Read more here: https://bit.ly/3ObfX8E

25/03/2026

MVision will be represented at the 6th International Congress of the Groupe Francophone de Radiothérapie en Urologie (GFRU), taking place March 26–27 in Lyon.

Our partner Meditest will be exhibiting at booth and will be available to discuss how MVision’s AI-powered solutions, including MVision Workspace+®, support efficient radiotherapy planning preparation while maintaining clinical oversight and consistent standards.

If you are attending the congress, be sure to stop by the booth to learn more.

CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

23/03/2026

MVision AI Founder and CEO Mahmudul Hasan will attend the ASMIRT 2026 Conference, taking place in Hobart from March 26 to 29. Organized by ASMIRT, the event brings together the medical radiation science community for four days of education, collaboration, and professional development.

The conference will feature expert speakers, hands-on workshops, site visits, and networking opportunities, covering topics ranging from clinical practice and education to diversity, mentoring, and emerging technologies.

Join us along with our partner AlphaXRT at booth #34–36 to learn how MVision AI’s solutions—including our recently TGA-approved AI-powered platform MVision Workspace+®—support more efficient radiotherapy preparation workflows while promoting consistent quality and clinical oversight.

CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

19/03/2026

Practical clinical insights are at the heart of the AAPM Spring Clinical Meeting 2026, taking place March 21–24 in Orlando.

If you are attending, stop by table 109 to meet MVision AI’s Martin Clay and Melody Blake. The meeting’s focus on real clinical implementation aligns closely with the work we do at MVision AI. Our solutions are designed to support radiotherapy teams by reducing manual work in treatment planning preparation and helping to bring greater consistency to clinical workflows.

See you in Orlando for a few days of conversations about clinical workflows and technology in medical physics.

17/03/2026

One week to go until our upcoming webinar with intellimed Switzerland on the latest innovations in RT workflows.

In this session, Rachel Buckingham, Customer Success Manager at MVision AI, will share practical clinical applications of MVision Workspace+® and demonstrate how its integrated AI-powered modules support accuracy and consistency in radiotherapy planning preparation.

The webinar is designed with radiation oncology professionals in Switzerland in mind and will include live demonstrations and an interactive Q&A.

📅 March 24 | 15:00 to 16:00 (Swiss time)
🔗 Register here: https://bit.ly/4brm2p8

*CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

16/03/2026

It was an honour to take part in the 39th Annual Meeting of the Japan High-Precision External Beam Radiotherapy Group / JASTRO in Tokyo.

MVision AI Founder & CEO Mahmudul Hasan and CSO Gregory Bolard presented on AI-assisted radiation therapy treatment preparation, sharing perspectives on how AI may support clinical decision-making and treatment planning preparation. The session was held as part of a sponsored seminar organized with our partner ITEM Corporation.

The discussions that followed were just as valuable as the presentation itself. Conversations with clinicians and researchers highlighted both the opportunities and the practical questions surrounding the use of AI in radiotherapy.

We are grateful for the warm welcome and thoughtful engagement from the Japanese radiotherapy community. Exchanges like these help shape the future of how new technologies can support patient care.

15/03/2026

The radiation oncology community gathers in Orlando for the RSS Scientific Meeting 2026 on March 19–21.

MVision AI’s Martin Clay and Melody Blake will be in attendance at table 20. If you are participating, come by to discuss how MVision is applying AI to support radiotherapy teams and bring greater consistency to treatment preparation.

Events like RSS are where many of the practical ideas start. We look forward to the discussions.

12/03/2026

The 38th TROG Annual Scientific Meeting (ASM) will take place in Melbourne on March 17-20, bringing together the radiation oncology community to share insights, research, and clinical perspectives from across the field.

Centered around the 2026 theme “Driving Intelligent Trials,” the program will highlight advances in trial design, AI-enabled research, equity in care, and strengthening clinical research systems.

MVision AI will be exhibiting at TROG 2026 together with our partner AlphaXRT. We’re especially excited to discuss MVision Workspace+® — our AI platform for radiotherapy — following its recent TGA approval in Australia and availability in New Zealand.

Drop by our booth to learn more.

*CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

10/03/2026

MVision AI will take part in the 39th Annual Meeting of the Japan High Precision External Beam Radiotherapy Group / Japanese Society for Radiation Oncology on March 14, 2026 in Tokyo at the Ochanomizu Sola City Conference Center.

MVision Founder & CEO Mahmudul Hasan will attend the meeting with our partner ITEM Corporation, and will also participate in a joint presentation:

🧠 AI-Assisted Radiation Therapy Treatment Preparation
📅 March 14 | 15:30–16:30

We value the opportunity to exchange perspectives with the Japanese radiotherapy community and contribute to ongoing discussions on how AI can support clinical decision-making and treatment planning.

*The technologies featured in this seminar have not yet received regulatory approval and are currently not available for sale in Japan. For more information, please contact info@mvision.ai or info@item-corp.jp.

03/03/2026

MVision AI is one of the sponsors of the ISROI Meeting 2026 in St. Gallen, Switzerland on March 6, focused on the latest developments in Radiation Oncology Informatics.

ISROI brings together experts from across Europe to explore data science, IT security, AI, foundation models, system integration, and workflow optimization in radiation oncology.

We’re pleased to support this event dedicated to addressing practical challenges and advancing technical innovation in radiation oncology informatics.

27/02/2026

In our latest ‘Expert Perspectives: AI in Radiotherapy’ interview, we speak with Michael Roche, Principal Physicist in Radiotherapy at the CUH/UCC Cancer Centre in Cork University Hospital.

Michael shares how AI-driven contouring has been safely integrated into a busy clinical workflow, what measurable impact it’s had on CT-to-treatment timelines, and why strong governance is essential as AI becomes more embedded in radiotherapy services.

This interview offers a clear, real-world view of how AI can support efficiency, consistency, and staff wellbeing—without replacing clinical judgement.

Read the full interview here:
https://bit.ly/4l1f7HC

25/02/2026

Cancer in the US continues to place growing pressure on patients, clinicians, and healthcare systems.

In our updated review of the landscape, we look at how cancer care and radiotherapy are evolving, from access and cost to the role of telemedicine and AI in treatment planning.

Where is progress being made? And where do gaps remain, especially for patients who live far from treatment centers or face financial barriers?

Read the full article for a data-driven overview of current trends in US oncology: https://bit.ly/3MtZn3f

Osoite

PaciuksenKatu 29
Helsinki
00270

Nettisivu

http://www.mvision.ai/

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita MVision AI :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Oma vastaanotto listan huipulle Klinikka Helsinki :ssa?

Jaa

Kategoria

Terveys